Viral infection and the pathogenesis of dilated cardiomyopathy.
about
EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseasesCoxsackievirus B3 infection and its mutation in Keshan diseaseEffect of lovastatin on coxsackievirus B3 infection in human endothelial cellsInhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand.Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditisReview of microbial infections and the immune response to cardiac antigens.Influence of myocarditis on left ventricular function.Characterization of enterovirus isolates from patients with heart muscle disease in a selenium-deficient area of China.Role of decay-accelerating factor domains and anchorage in internalization of Dr-fimbriated Escherichia coliReovirus induction of and sensitivity to beta interferon in cardiac myocyte cultures correlate with induction of myocarditis and are determined by viral core proteins.Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease.Virus-induced dilated cardiomyopathy is characterized by increased levels of fibrotic extracellular matrix proteins and reduced amounts of energy-producing enzymes.Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditisCoxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era.Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathyComplement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes.Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strainThe cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region.Reovirus-induced acute myocarditis in mice correlates with viral RNA synthesis rather than generation of infectious virus in cardiac myocytes.Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditisCoxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors.Serological detection and analysis of anti-VP1 responses against various enteroviruses (EV) (EV-A, EV-B and EV-C) in Chinese individuals.Cleavage of DAP5 by coxsackievirus B3 2A protease facilitates viral replication and enhances apoptosis by altering translation of IRES-containing genes.Chagas Cardiomyopathy in New Orleans and the Southeastern United States.Mucosal immunization with high-mobility group box 1 in chitosan enhances DNA vaccine-induced protection against coxsackievirus B3-induced myocarditis.Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management.Caspase-8 and FLIP regulate RIG-I/MDA5-induced innate immune host responses to picornaviruses.Coxsackievirus B3 replication and pathogenesis.Experimental myocarditis induced by two different coxsackievirus B3 variants: aspects of pathogenesis and comparison of diagnostic methods.Viral myocarditis--diagnosis, treatment options, and current controversies.Myocarditis and the military patient.Pathophysiology and prevention of sudden cardiac death.Heat shock protein 70 promotes coxsackievirus B3 translation initiation and elongation via Akt-mTORC1 pathway depending on activation of p70S6K and Cdc2.Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research.Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in miceIdentification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural protein.Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis.
P2860
Q28076658-389AF232-3F98-4AF3-89BD-C6408AEA655AQ28287825-87CDDD77-D37B-413A-A732-FAF19C086BF3Q28303547-29A92E42-C17F-4BA1-84E4-862B287350BAQ33781261-D6D3534E-512E-4860-A8A3-F2D517A92408Q33828989-428F5EAC-695A-42C7-9B25-41E510F7552BQ33935066-4A3CDA36-4583-4125-B6F6-517590615786Q33958656-3650FEBA-083C-4EAE-B026-C54CD7BAE936Q33969834-7837783A-DBAA-4521-9AA3-BFB04A3D0714Q34003569-6223877E-5143-4122-9D80-DF954603A6B4Q34069681-A05704E7-7087-4F06-8A19-5C355AB16AF3Q34138862-831A53B0-CB1A-41C8-8BEA-A90B0FB1E95CQ34219925-37CE2841-29BF-4555-A6E0-D4D3FDB042A1Q34299695-D4308CD5-3F0C-4FDB-BF20-B26EB753FA1CQ34333784-2BDFA068-4B31-45CA-8510-92AD8834E260Q34555483-8B5308E7-2AC0-485F-9CFA-13F3EB502170Q35582913-ECA0B8E5-72FA-4F43-B220-E9E552DBE9AAQ35747641-33DBE99A-51F3-4157-A2EC-629301630599Q35764808-D7181234-43E8-4F61-9293-1A28874C555CQ35843889-D7BED5DD-99E5-4C08-A626-4B4EBE62A0C4Q35869765-E0451C68-5522-40AC-8223-41FA566D14D3Q36370549-4264907B-E9AC-4990-8472-1190676EE8B1Q36607055-A3CD8200-C94E-48B0-BDE3-64D37509DC78Q36621116-0A8B8923-E54C-4283-83FF-EA09C1711972Q36799293-4D309D9F-84BE-4DD8-953A-0CA578B400B1Q37259017-BD51FED0-DD75-4193-9430-CA57150142B8Q37335446-A03BE268-62B6-46BB-B35C-CE36054BFF46Q37385438-A5460374-67CB-4E32-82A8-C155B0F5E82AQ38056870-4FF10D4C-2653-46A0-9FF5-291AA464C89CQ38090473-4A56D083-F858-46CC-B3F4-F356FE0002DEQ38417041-38EC1A0B-FD4C-4E3A-912F-D7F42B61B6F1Q38479686-8CAAF710-9DB0-4FAF-BDB1-8FDAB7E86101Q38551013-FFC9C512-8C74-4B25-A8A4-10CDB6085E3AQ38561472-41631109-CFCF-41EE-A85E-924EB2E3774EQ38664314-761B6A87-E62C-4270-8A35-FD70B9289F5EQ38720928-73CFFA15-5219-4D6B-BB1F-F812968E1822Q38986995-C920AB47-F32C-447C-AF9C-C7C7166E3569Q39976598-A2F9FD0F-75E5-45B9-B38D-DC28DC19FB37Q40585877-01F88C89-7AFA-43C4-B51F-BFD7DBD3226FQ41738937-69F95C30-B8DC-4824-8142-0A4734BD3E78Q41834966-09162EDB-9D84-4073-AAD7-30EE0A70FC9C
P2860
Viral infection and the pathogenesis of dilated cardiomyopathy.
description
1994 nî lūn-bûn
@nan
1994 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Viral infection and the pathogenesis of dilated cardiomyopathy.
@ast
Viral infection and the pathogenesis of dilated cardiomyopathy.
@en
Viral infection and the pathogenesis of dilated cardiomyopathy.
@nl
type
label
Viral infection and the pathogenesis of dilated cardiomyopathy.
@ast
Viral infection and the pathogenesis of dilated cardiomyopathy.
@en
Viral infection and the pathogenesis of dilated cardiomyopathy.
@nl
prefLabel
Viral infection and the pathogenesis of dilated cardiomyopathy.
@ast
Viral infection and the pathogenesis of dilated cardiomyopathy.
@en
Viral infection and the pathogenesis of dilated cardiomyopathy.
@nl
P2093
P356
P1433
P1476
Viral infection and the pathogenesis of dilated cardiomyopathy.
@en
P2093
P304
P356
10.1161/01.RES.74.2.182
P577
1994-02-01T00:00:00Z